Epigallocatechin-3-gallate-mediated cardioprotection by Akt/GSK-3β/caveolin signalling in H9c2 rat cardiomyoblasts

BACKGROUND: Epigallocatechin-3-gallate (EGCg) with its potent anti-oxidative capabilities is known for its beneficial effects ameliorating oxidative injury to cardiac cells. Although studies have provided convincing evidence to support the cardioprotective effects of EGCg, it remains unclear whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Shih-Ron, Hsu, Chen-Sen, Lu, Chen-Hua, Chen, Wei-Cheng, Chiu, Chun-Hwei, Liou, Ying-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871020/
https://www.ncbi.nlm.nih.gov/pubmed/24251870
http://dx.doi.org/10.1186/1423-0127-20-86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871020/
https://www.ncbi.nlm.nih.gov/pubmed/24251870
http://dx.doi.org/10.1186/1423-0127-20-86

Ejemplares similares